U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 494

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:64570986-64572288
GRCh38:
Chr11:64803514-64804816
MEN1V451fsMultiple endocrine neoplasia, type 1Pathogenic
(Jun 23, 2018)
criteria provided, single submitter
2.
GRCh37:
Chr11:64570986-64572288
GRCh38:
Chr11:64803514-64804816
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Sep 3, 2016)
criteria provided, single submitter
3.
GRCh37:
Chr11:64570986-64577604
GRCh38:
Chr11:64803514-64810132
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Aug 2, 2016)
criteria provided, single submitter
4.
GRCh37:
Chr11:64571394
GRCh38:
Chr11:64803922
MEN1Somatotroph adenomaLikely pathogenic
(Dec 5, 2017)
criteria provided, single submitter
5.
GRCh37:
Chr11:64571674-64572290
GRCh38:
Chr11:64804202-64804818
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Sep 14, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr11:64571796-64578188
GRCh38:
Chr11:64804324-64810716
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Jun 18, 2019)
criteria provided, single submitter
7.
GRCh37:
Chr11:64571808
GRCh38:
Chr11:64804336
MEN1Somatotroph adenomaPathogenic
(Dec 5, 2017)
criteria provided, single submitter
8.
GRCh37:
Chr11:64571883
GRCh38:
Chr11:64804411
MEN1Q531*, Q586*, Q591*, Q628*, Q551*, Q593*, Q633*Multiple endocrine neoplasia, type 1Likely pathogenic
(Feb 9, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr11:64571900
GRCh38:
Chr11:64804428
MEN1T545fs, T622fs, T585fs, T580fsMultiple endocrine neoplasia, type 1Likely pathogenic
(Aug 9, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr11:64571907
GRCh38:
Chr11:64804435
MEN1Q523*, Q578*, Q585*, Q620*, Q543*, Q583*, Q625*Multiple endocrine neoplasia, type 1Likely pathogenic
(Aug 7, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr11:64571911-64571931
GRCh38:
Chr11:64804439-64804459
MEN1Hereditary cancer-predisposing syndromeLikely pathogenic
(Sep 15, 2015)
criteria provided, single submitter
12.
GRCh37:
Chr11:64571914
GRCh38:
Chr11:64804442
MEN1K541fs, K618fs, K581fs, K576fsHereditary cancer-predisposing syndromeLikely pathogenic
(Aug 19, 2016)
criteria provided, single submitter
13.
GRCh37:
Chr11:64571918-64571996
GRCh38:
Chr11:64804446-64804524
MEN1G513fs, G548fs, G553fs, G590fsHereditary cancer-predisposing syndromePathogenic
(Dec 6, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr11:64571929
GRCh38:
Chr11:64804457
MEN1N536fs, N576fs, N613fs, N571fsHereditary cancer-predisposing syndromeLikely pathogenic
(Sep 21, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr11:64571952
GRCh38:
Chr11:64804480
MEN1E563*, E568*, E528*, E605*not providedPathogenic
(Apr 24, 2017)
criteria provided, single submitter
16.
GRCh37:
Chr11:64571953-64571954
GRCh38:
Chr11:64804481-64804482
MEN1E568fs, E528fs, E563fs, E605fsnot providedPathogenic
(Jan 21, 2013)
no assertion criteria provided
17.
GRCh37:
Chr11:64571957
GRCh38:
Chr11:64804485
MEN1M506R, M526R, M566R, M561R, M608R, M603R, M568RHereditary cancer-predisposing syndromeLikely pathogenic
(Mar 22, 2017)
criteria provided, single submitter
18.
GRCh37:
Chr11:64571960-64571967
GRCh38:
Chr11:64804488-64804495
MEN1M563fs, M523fs, M558fs, M600fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 27, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr11:64571964
GRCh38:
Chr11:64804492
MEN1K564*, K601*, K566*, K606*, K559*, K524*, K504*Hereditary cancer-predisposing syndromePathogenic
(May 25, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr11:64571964-64571965
GRCh38:
Chr11:64804492-64804493
MEN1K524fs, K564fs, K601fs, K559fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 9, 2021)
criteria provided, single submitter
21.
GRCh37:
Chr11:64571966-64571997
GRCh38:
Chr11:64804494-64804525
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Jan 11, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr11:64571969
GRCh38:
Chr11:64804497
MEN1K557fs, K522fs, K562fs, K599fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 28, 2021)
criteria provided, single submitter
23.
GRCh37:
Chr11:64571970
GRCh38:
Chr11:64804498
MEN1K557E, K562E, K522E, K599EHereditary cancer-predisposing syndromeLikely pathogenic
(Jun 23, 2015)
criteria provided, single submitter
24.
GRCh37:
Chr11:64571971-64571974
GRCh38:
Chr11:64804499-64804502
MEN1S555fs, S520fs, S560fs, S597fsHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1Pathogenic/Likely pathogenic
(Feb 5, 2019)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr11:64571973
GRCh38:
Chr11:64804501
MEN1E556*, E561*, E598*, E521*Hereditary cancer-predisposing syndromePathogenic
(Nov 22, 2015)
criteria provided, single submitter
26.
GRCh37:
Chr11:64571975
GRCh38:
Chr11:64804503
MEN1S555N, S560N, S597N, S520Nnot specified, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1
Pathogenic/Likely pathogenic
(Jul 31, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr11:64571979
GRCh38:
Chr11:64804507
MEN1Q519fs, Q554fs, Q596fs, Q559fsMultiple endocrine neoplasia, type 1Pathogenic
(Nov 12, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr11:64571979
GRCh38:
Chr11:64804507
MEN1Q554*, Q559*, Q519*, Q596*Hereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 1
Pathogenic
(Aug 13, 2021)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr11:64571981-64571982
GRCh38:
Chr11:64804509-64804510
MEN1F518fs, F553fs, F558fs, F595fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 17, 2021)
criteria provided, single submitter
30.
GRCh37:
Chr11:64571985
GRCh38:
Chr11:64804513
MEN1T552S, T557S, T517S, T594SAdrenocortical adenomaPathogenic
(Dec 1, 1999)
no assertion criteria provided
31.
GRCh37:
Chr11:64571988
GRCh38:
Chr11:64804516
MEN1L593fs, L516fs, L551fs, L556fsnot providedPathogenic
(May 30, 2014)
criteria provided, single submitter
32.
GRCh37:
Chr11:64571999-64572000
GRCh38:
Chr11:64804527-64804528
MEN1E552fs, E512fs, E589fs, E547fsHereditary cancer-predisposing syndromePathogenic
(Jul 9, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr11:64572020-64572021
GRCh38:
Chr11:64804548-64804549
MEN1P540fs, P505fs, P545fs, P582fsnot providedPathogenic
(Jan 31, 2014)
criteria provided, single submitter
34.
GRCh37:
Chr11:64572021-64572037
GRCh38:
Chr11:64804549-64804565
MEN1A577fs, A500fs, A540fs, A535fsnot providedLikely pathogenic
(Apr 14, 2017)
criteria provided, single submitter
35.
GRCh37:
Chr11:64572024-64572025
GRCh38:
Chr11:64804552-64804553
MEN1A504fs, A539fs, A544fs, A581fsHereditary cancer-predisposing syndrome, not providedPathogenic/Likely pathogenic
(Sep 2, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr11:64572030
GRCh38:
Chr11:64804558
MEN1V542fs, V537fs, V502fs, V579fsHereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 1
Pathogenic/Likely pathogenic
(May 19, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:64572049
GRCh38:
Chr11:64804577
MEN1G496fs, G536fs, G531fs, G573fsnot provided, Multiple endocrine neoplasia, type 1Pathogenic
(Dec 17, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:64572060
GRCh38:
Chr11:64804588
MEN1R527*, R532*, R569*, R492*not provided, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1
Pathogenic
(Oct 15, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr11:64572065
GRCh38:
Chr11:64804593
MEN1T567fs, T525fs, T490fs, T530fsHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1Pathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr11:64572074-64572075
GRCh38:
Chr11:64804602-64804603
MEN1V487fs, V522fs, V527fs, V564fsMultiple endocrine neoplasia, type 1Likely pathogenic
(Jan 8, 2020)
criteria provided, single submitter
41.
GRCh37:
Chr11:64572083
GRCh38:
Chr11:64804611
MEN1P484fs, P519fs, P524fs, P561fsnot provided, Multiple endocrine neoplasia, type 1Pathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr11:64572090-64572091
GRCh38:
Chr11:64804618-64804619
MEN1K482fs, K517fs, K522fs, K559fsnot providedPathogenic
(Jan 13, 2017)
criteria provided, single submitter
43.
GRCh37:
Chr11:64572090-64572091
GRCh38:
Chr11:64804618-64804619
MEN1K517fs, K559fs, K482fs, K522fsHereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 1
Pathogenic/Likely pathogenic
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:64572090
GRCh38:
Chr11:64804618
MEN1K517*, K522*, K482*, K559*Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1Pathogenic
(Aug 12, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr11:64572091
GRCh38:
Chr11:64804619
MEN1K482fs, K517fs, K522fs, K559fsnot providedPathogenic
(Feb 16, 2016)
criteria provided, single submitter
46.
GRCh37:
Chr11:64572091-64572092
GRCh38:
Chr11:64804619-64804620
MEN1K482fs, K517fs, K522fs, K559fsnot providedPathogenic
(Sep 20, 2016)
criteria provided, single submitter
47.
GRCh37:
Chr11:64572092-64572093
GRCh38:
Chr11:64804620-64804621
MEN1R481fs, R521fs, R558fs, R516fsnot provided, Multiple endocrine neoplasia, type 1, Hereditary cancer-predisposing syndrome
Pathogenic
(Jul 28, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr11:64572093
GRCh38:
Chr11:64804621
MEN1R516fs, R481fs, R521fs, R558fsHereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 1
Pathogenic
(Feb 21, 2023)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr11:64572098-64572107
GRCh38:
Chr11:64804626-64804635
MEN1V476fs, V511fs, V553fs, V516fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 27, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr11:64572100
GRCh38:
Chr11:64804628
MEN1R521fs, R558fs, R481fs, R516fsMultiple endocrine neoplasia, type 1, Hereditary cancer-predisposing syndromePathogenic/Likely pathogenic
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr11:64572104
GRCh38:
Chr11:64804632
MEN1S512*, S517*, S477*, S554*Multiple endocrine neoplasia, type 1Pathogenic
(Jul 14, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr11:64572104-64572105
GRCh38:
Chr11:64804632-64804633
MEN1S512fs, S477fs, S517fs, S554fsHereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 1
Pathogenic
(Apr 6, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr11:64572106-64572107
GRCh38:
Chr11:64804634-64804635
MEN1S554fs, S477fs, S517fs, S512fsMultiple endocrine neoplasia, type 1Pathogenic
(Sep 2, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr11:64572109-64572110
GRCh38:
Chr11:64804637-64804638
MEN1A552fs, A510fs, A475fs, A515fsHereditary cancer-predisposing syndromePathogenic
(Jul 30, 2015)
criteria provided, single submitter
55.
GRCh37:
Chr11:64572117
GRCh38:
Chr11:64804645
MEN1Q473*, Q513*, Q508*, Q550*Multiple endocrine neoplasia, type 1Pathogenic
(Mar 31, 2019)
criteria provided, single submitter
56.
GRCh37:
Chr11:64572131-64572132
GRCh38:
Chr11:64804659-64804660
MEN1G468fs, G508fs, G545fs, G503fsHereditary cancer-predisposing syndromePathogenic
(Jan 14, 2013)
criteria provided, single submitter
57.
GRCh37:
Chr11:64572133-64572134
GRCh38:
Chr11:64804661-64804662
MEN1L509fs, L546fs, L504fs, L469fsMultiple endocrine neoplasia, type 1, not providedPathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr11:64572152
GRCh38:
Chr11:64804680
MEN1K461fs, K496fs, K501fs, K538fsnot providedPathogenic
(Aug 16, 2017)
criteria provided, single submitter
59.
GRCh37:
Chr11:64572161
GRCh38:
Chr11:64804689
MEN1P458fs, P493fs, P498fs, P535fsMultiple endocrine neoplasia, type 1, Hereditary cancer-predisposing syndromePathogenic
(Aug 12, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr11:64572166
GRCh38:
Chr11:64804694
MEN1E491fs, E533fs, E456fs, E496fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 9, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr11:64572168
GRCh38:
Chr11:64804696
MEN1E456*, E498*, E491*, E436*, E496*, E533*, E538*Multiple endocrine neoplasia, type 1Likely pathogenic
(May 25, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr11:64572175
GRCh38:
Chr11:64804703
MEN1K453fs, K488fs, K530fs, K493fsHereditary cancer-predisposing syndrome, not providedPathogenic
(Dec 2, 2015)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr11:64572183
GRCh38:
Chr11:64804711
MEN1E451*, E486*, E491*, E528*Multiple endocrine neoplasia, type 1Pathogenic
(Jul 30, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr11:64572194
GRCh38:
Chr11:64804722
MEN1G524fs, G447fs, G482fs, G487fsHereditary cancer-predisposing syndromePathogenic
(Aug 2, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr11:64572198-64572204
GRCh38:
Chr11:64804726-64804732
MEN1R479fs, R521fs, R444fs, R484fsMultiple endocrine neoplasia, type 1Pathogenic
(May 16, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr11:64572200-64572245
GRCh38:
Chr11:64804728-64804773
MEN1A430fs, A465fs, A470fs, A507fsnot providedLikely pathogenic
(Aug 28, 2014)
criteria provided, single submitter
67.
GRCh37:
Chr11:64572202
GRCh38:
Chr11:64804730
MEN1R480fs, R485fs, R445fs, R522fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 28, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr11:64572209-64572210
GRCh38:
Chr11:64804737-64804738
MEN1E442fs, E477fs, E482fs, E519fsnot providedPathogenic
(Dec 27, 2017)
criteria provided, single submitter
69.
GRCh37:
Chr11:64572210
GRCh38:
Chr11:64804738
MEN1E442fs, E519fs, E477fs, E482fsHereditary cancer-predisposing syndromePathogenic
(Jul 30, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr11:64572210
GRCh38:
Chr11:64804738
MEN1E477*, E482*, E519*, E442*not provided, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1
Pathogenic
(May 23, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr11:64572219
GRCh38:
Chr11:64804747
MEN1E439fs, E474fs, E479fs, E516fsMultiple endocrine neoplasia, type 1Pathogenic
(Sep 2, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr11:64572222
GRCh38:
Chr11:64804750
MEN1E473*, E520*, E418*, E438*, E480*, E478*, E515*Hereditary cancer-predisposing syndromePathogenic
(Apr 22, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr11:64572225-64572226
GRCh38:
Chr11:64804753-64804754
MEN1G477fs, G514fs, G437fs, G472fsHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1Pathogenic
(Aug 9, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr11:64572226
GRCh38:
Chr11:64804754
MEN1W471*, W436*, W476*, W513*Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1Pathogenic
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr11:64572226-64572239
GRCh38:
Chr11:64804754-64804767
MEN1A432fs, A467fs, A472fs, A509fsHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1Pathogenic
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr11:64572227
GRCh38:
Chr11:64804755
MEN1W471*, W476*, W436*, W513*Multiple endocrine neoplasia, type 1Pathogenic
(Jul 14, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr11:64572234-64572235
GRCh38:
Chr11:64804762-64804763
MEN1E434fs, E474fs, E469fs, E511fsMultiple endocrine neoplasia, type 1Pathogenic
(Jul 14, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr11:64572243-64572246
GRCh38:
Chr11:64804771-64804774
MEN1A470fs, A507fs, A465fs, A430fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 27, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr11:64572246
GRCh38:
Chr11:64804774
MEN1A470fs, A507fs, A430fs, A465fsMultiple endocrine neoplasia, type 1Pathogenic
(Jul 14, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr11:64572247-64572248
GRCh38:
Chr11:64804775-64804776
MEN1A465fs, A430fs, A470fs, A507fsMultiple endocrine neoplasia, type 1Pathogenic
(Jun 9, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr11:64572247-64572248
GRCh38:
Chr11:64804775-64804776
MEN1A430fs, A465fs, A470fs, A507fsMultiple endocrine neoplasia, type 1Pathogenic
(Jul 17, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr11:64572247-64572248
GRCh38:
Chr11:64804775-64804776
MEN1A432fs, A467fs, A472fs, A509fsHereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 1
Pathogenic
(May 20, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr11:64572247-64572248
GRCh38:
Chr11:64804775-64804776
MEN1Hereditary cancer-predisposing syndromePathogenic
(Jul 11, 2015)
criteria provided, single submitter
84.
GRCh37:
Chr11:64572248
GRCh38:
Chr11:64804776
MEN1A469fs, A506fs, A429fs, A464fsnot specifiedLikely pathogenic
(Feb 14, 2017)
criteria provided, single submitter
85.
GRCh37:
Chr11:64572249-64572250
GRCh38:
Chr11:64804777-64804778
MEN1A469fs, A506fs, A429fs, A464fsHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 1Pathogenic
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr11:64572249
GRCh38:
Chr11:64804777
MEN1A506fs, A469fs, A429fs, A464fsHereditary cancer-predisposing syndromePathogenic
(Jul 16, 2014)
criteria provided, single submitter
87.
GRCh37:
Chr11:64572252
GRCh38:
Chr11:64804780
MEN1E463*, E470*, E428*, E468*, E505*, E408*, E510*Hereditary cancer-predisposing syndromePathogenic
(Aug 19, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr11:64572256-64572259
GRCh38:
Chr11:64804784-64804787
MEN1E503fs, E461fs, E466fs, E426fsHereditary cancer-predisposing syndromePathogenic
(Oct 12, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr11:64572257-64572264
GRCh38:
Chr11:64804785-64804792
MEN1S464fs, S424fs, S501fs, S459fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 9, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr11:64572261
GRCh38:
Chr11:64804789
MEN1not providedPathogenic
(Mar 10, 2017)
criteria provided, single submitter
91.
GRCh37:
Chr11:64572261
GRCh38:
Chr11:64804789
MEN1R460*, R465*, R502*, R425*Hereditary cancer-predisposing syndrome, not provided, Multiple endocrine neoplasia, type 1
Pathogenic
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr11:64572272-64572283
GRCh38:
Chr11:64804800-64804811
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Jul 1, 2004)
no assertion criteria provided
93.
GRCh37:
Chr11:64572280-64572291
GRCh38:
Chr11:64804808-64804819
MEN1not provided, Multiple endocrine neoplasia, type 1Likely pathogenic
(Oct 8, 2021)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr11:64572282-64572283
GRCh38:
Chr11:64804810-64804811
MEN1Q418fs, Q453fs, Q458fs, Q495fsMultiple endocrine neoplasia, type 1Pathogenic
(Aug 26, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr11:64572289
GRCh38:
Chr11:64804817
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Aug 20, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr11:64572289
GRCh38:
Chr11:64804817
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Aug 12, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr11:64572289
GRCh38:
Chr11:64804817
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Oct 15, 2019)
criteria provided, single submitter
98.
GRCh37:
Chr11:64572290
GRCh38:
Chr11:64804818
MEN1Hereditary cancer-predisposing syndromeLikely pathogenic
(Sep 5, 2019)
criteria provided, single submitter
99.
GRCh37:
Chr11:64572290
GRCh38:
Chr11:64804818
MEN1Multiple endocrine neoplasia, type 1Pathogenic
(Sep 10, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr11:64572478-64572579
GRCh38:
Chr11:64805006-64805107
MEN1Multiple endocrine neoplasia, type 1Likely pathogenic
(Nov 27, 2019)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination